Resultados globales: 5 registros encontrados en 0.02 segundos.
Artículos, Encontrados 4 registros
Documentos de investigación, Encontrados 1 registros
Artículos Encontrados 4 registros  
1.
13 p, 1.2 MB Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy : A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research / Schoettler, M.L. (Children's Healthcare of Atlanta) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Cho, Byung-Sik (The Catholic University of Korea) ; Dandoy, Christopher E. (Cincinnati Children's Hospital Medical Center) ; Ho, Vincent Trien Vinh (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ; Jodele, Sonata (Cincinnati Children's Hospital Medical Center) ; Moissev, I. (Pavlov First Saint Petersburg State Medical University) ; Sańchez Ortega, Isabel (European Society for Bone Marrow Transplant) ; Srivastava, Alok (Christian Medical College Vellore) ; Atsuta, Yoshiko (Aichi Medical University) ; Carpenter, Paul A. (Seattle Children's Hospital) ; Koreth, John (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ; Kröger, Nicolaus M. (Ohio State. University) ; Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ; Page, Kristin M. (Medical College of Wisconsin) ; Popat, Uday R. (The University of Texas MD Anderson Cancer Center) ; Shaw, Bronwen E. (Medical College of Wisconsin) ; Sureda Balari, Anna Maria (Institut Catala d'Oncologia-Hospital Duran i Reynals) ; Soiffer, Robert J. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ; Vasu, Sumithira V. (Ohio State. University)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic cell transplantation (HCT) associated with significant morbidity and mortality. [...]
2023 - 10.1016/j.jtct.2022.11.015
Transplantation and Cellular Therapy, Vol. 29 Núm. 3 (march 2023) , p. 151-163  
2.
8 p, 930.0 KB Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study / Escamilla Gómez, Virginia (Universidad de Sevilla) ; García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ; López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ; Márquez Malaver, Francisco J. (Universidad de Sevilla) ; Caballero-Velázquez, Teresa (Universidad de Sevilla) ; González Sierra, Pedro A. (Hospital Universitario (Granada)) ; Viguria Alegría, María C. (Complejo Hospitalario de Navarra) ; Parra Salinas, Ingrid M. (Hospital Universitario Miguel Servet (Saragossa)) ; Calderón Cabrera, Cristina (Universidad de Sevilla) ; González Vicent, Marta (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Rodríguez Torres, Nancy (Universidad de Sevilla) ; Parody Porras, Rocío (Instituto Catalá de Oncología Hospitalet) ; Ferra Coll Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Orti, Guillermo (Hospital Universitari Vall d'Hebron) ; Valcárcel Ferreiras, David (Hospital Universitari Vall d'Hebron) ; de la Cámara Llanzá, Rafael (Hospital Universitario de la Princesa (Madrid)) ; Molés, Paula (Hospital Universitari i Politècnic La Fe (València)) ; Velázquez-Kennedy, Kyra (Hospital Universitari Ramon y Cajal) ; João Mende, María (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Caballero Barrigón, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Saavedra Gerosa, Silvanna (Institut d'Investigació Biomèdica Sant Pau) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Poch, Marc (Clinic Hospital Universitari de Valencia) ; Zudaire Ripa, María T. (Complejo Hospitalario de Navarra) ; Díaz Pérez, Miguel A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Molina Angulo, Blanca (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Sánchez Ortega, Isabel (Instituto Catalá de Oncología Hospitalet) ; Sanz Caballer, Jaime (Hospital Universitari i Politècnic La Fe (València)) ; Montoro Gómez, Juan (Hospital Universitari i Politècnic La Fe (València)) ; Espigado Tocino, Ildefonso (Universidad de Sevilla) ; Pérez-Simón, José A. (Universidad de Sevilla) ; Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648  
3.
8 p, 1.8 MB Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) / Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ; Putter, Hein (Leiden University Medical Center) ; Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ; Busto, María Paula (EBMT Registry) ; McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ; Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Ayuk, Francis (University Medical Center Hamburg) ; Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ; Beguin, Yves (CHU of Liège and University of Liège) ; de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ; Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ; Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ; Corbacioglu, Selim (University Children's Hospital Regensburg) ; Dolstra, Harry (Radboud University Medical Center) ; Duarte, Rafael (Universidad Autónoma de Madrid) ; Duléry, Rémy (Sorbonne Université) ; Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ; Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Hamad, Nada (University of Notre Dame Australia) ; Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ; Kroeger, Nicolaus (University Medical Center Hamburg) ; Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ; Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ; Mensil, Florence (Agence de la Biomédecine) ; Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ; Mohty, Mohamad (Sorbonne University) ; Oldani, Elena (Italian National BMT Registry) ; Orchard, Kim (University Hospital Southampton NHS) ; Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ; Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; de Latour, Régis Peffault (BMT unit Paris Cité University) ; Poirel, Hélène A. (Belgian Transplant Registry) ; Rintala, Tuula (King's College Hospital NHS Foundation Trust) ; Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ; Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Sanchez-Guijo, Fermin (CIC-University of Salamanca) ; Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Trnková, Marie (Czech registry Czech Republic) ; Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ; Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ; de Wreede, Liesbeth C. (Leiden University Medical Center) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8  
4.
14 p, 321.4 KB Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor : id A Retrospective Comparative Analysis / Parody Porras, Rocío (Institut d'Investigació Biomèdica de Bellvitge) ; Sánchez Ortega, Isabel (Institut d'Investigació Biomèdica de Bellvitge) ; Ferrá, Christelle (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Guardia, Ramon (Hospital Universitari de Girona Doctor Josep Trueta) ; Talarn, Carme (Hospital Universitari Joan XXIII de Tarragona) ; Encuentra, Maite (Institut d'Investigació Biomèdica de Bellvitge) ; Fort, Eduard (Institut Català d'Oncologia) ; López, David (Institut Català d'Oncologia) ; Morgades, Mireia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Alonso, Eva (Banc de Sang i Teixits de Catalunya) ; Ortega, Sandra (Banc de Sang i Teixits de Catalunya) ; Sarrá, Josep (Hospital Universitari Joan XXIII de Tarragona) ; Gallardo, David (Hospital Universitari de Girona Doctor Josep Trueta) ; Ribera, Josep M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sureda, Anna (Institut d'Investigació Biomèdica de Bellvitge) ; Universitat Autònoma de Barcelona
Introduction: Biosimilars of granulocyte colony-stimulating factors (G-CSF) have shown similar efficacy to originator filgrastim (Neupogen [NEU]; Amgen Inc. ) as prophylaxis in neutropenia and in the mobilization of stem cells in patients receiving combination chemotherapy with G-CSF. [...]
2020 - 10.1007/s40487-020-00115-3
Oncology and Therapy, Vol. 8 Num. 2 (2020) , p. 311-324  

Documentos de investigación Encontrados 1 registros  
1.
94 p, 5.2 MB Avances en la profilaxis antifúngica primaria en la fase precoz del trasplante alogénico / Sánchez-Ortega, Isabel ; Duarte Palomino, Rafael F., dir. ; Sierra Gil, Jordi, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
En el trasplante alogénico (alo-TPH), las infecciones fúngicas invasivas (IFI) siguen teniendo un gran impacto sobre la morbi-mortalidad. La profilaxis primaria, es la única estrategia farmacológica de manejo de las infecciones fúngicas que ha demostrado disminuir la mortalidad global y la mortalidad relacionada con la IFI en el alo-TPH y en base a una revisión sistemática y metaanálisis de 64 estudios randomizados [Robenshtok E et al. [...]
Invasive fungal infections (IFI) are recognized as the leading infectious cause of mortality in allogeneic blood and marrow transplant (allo-BMT) recipients. As a general antifungal strategy, primary prophylaxis reduces all-cause mortality and IFI-related mortality in allo-BMT, and should be used for all allo-BMT recipients according to a systematic review and meta-analysis of 64 randomized controlled trials [Robenshtok E et al. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.